Dr Rao Papineni will deliver “Combinatorial energy based cancer therapeutics” at 17th International Conference for Radiation Research ICRR 2023 Canada.
Technologies: High-Throughput Integrated Radiation Clonogenic Assay & Spatial Radiation Treatment
The development of this product was supported through Grant-in-Aid from National Cancer Institute, NCI-SBIR
Nanomedicine: Radiation activated Photodynamic Cancer Therapy
The development of this product was supported through Grant-in-Aid from National Cancer Institute, NCI-SBIR
PH074 Anticancer PH477 Infection PH744 Countermeasure
One-Two Punch Polypharmacological Therapeutics: anticancer, senolytic, & antiviral properties
AI workflow in Preclinical & Translational Oncology
IAEA
International Atomic Energy Agency
Dr Papineni Joined IAEA- NCI meet from 30 October-1 November 2018 at Vienna establishing a Technical Manual for Intrinsic Radiation Sensitivity assay using clonogenic cell survival (TMIRS). Norms for the Dosimetry and interlaboratory experimentation harmonization.
A special issue of Translational Cancer Research (TCR) on “Applications of Nanotechnology in Radiation Research”, we showcase the innovative and novel approaches in the utility of nanotechnology in Radiation therapy.
PACT&Health is Awarded a Prestigious National Cancer Institute NCI SBIR contract to develop Anti-Cancer Radiation Drug Screening Platform.
September 2019
PACT&Health is pleased to receive a 1.9 M$ Contract Grant to develop a High-Throughput X-Ray Irradiation Platform to screen novel modulators for Clinical Cancer Radiotherapy.
"TECHNOLOGIES"
Towards Engineered Precision Assays and Poly Pharmacological Cure-Based Cancer Drug/ Therapy Solutions.
Our Vision
To provide a platform for Cancer Biology, Radiation Oncology, and Radiation Biology for utilizing advanced preclinical and translational technologies in improving biomarker database and impact precision cancer treatment globally. PACT & Health established in 2013, further focusses in developing Radiation modifying agents such as radiosensitizers and radioprotectants.
LATEST NEWS
-
Towards targeted-gold nanoparticle enhanced chemoradiation therapy of pancreatic cancer
https://aacrjournals.org/cancerres/issue/82/12_Supplement -
Gene Expression and Early Radiation Response of Two Distinct Neuroblastoma Cell Lines
Abstract Introduction: Neuroblastoma is one of the most common childhood cancers with one of the lowest survival rates, accounting for 15% of childhood cancer mortality. Approximately half of children treated for... -
2-deoxy-D-glucose mitigates Citrobacter rodentium and dibenzazepine-induced gastrointestinal damage and colitis: novel implications of 2-DG polypharmacopea
Abstract Purpose Citrobacter rodentium (CR) infection coupled with blocking Notch/Wnt signaling via γ-secretase inhibitor dibenzazepine (DBZ) disrupts the gastro-intestinal (GI) barrier and induces colitis, akin to ionizing radiation (IR)-induced GI-injury. We investigated... -
Differential expression of deubiquitinating enzymes and its related DNA damage response genes in neuroblastoma heterogeneity
Abstract LB015: Differential expression of deubiquitinating enzymes and its related DNA damage response genes in neuroblastoma heterogeneity Abstract SK-N-AS and SK-N-DZ are two cell lines of pediatric solid tumors neuroblastomas well characterized... -
Technological advancements in cancer diagnostics: Improvements and limitations
https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1764